Remove 2023 Remove Homecare Remove Hospice companies Remove Medicare
article thumbnail

The Public Hospice Companies Most Likely to Acquire in 2024

Hospice News

After a rocky year for M&A, two of the publicly traded hospice providers are poised to pursue more deals in 2024. Based on 2023 earnings trends, The Pennant Group (NASDAQ: PNTG) and Addus HomeCare Cop. The post The Public Hospice Companies Most Likely to Acquire in 2024 appeared first on Hospice News.

article thumbnail

Publicly Traded Hospice Execs See Signs of Improvement in Labor Market

Hospice News

Some hospice company leaders have signaled the labor market may be showing signs of stabilization. The note showed that the high rate of inflation is driving higher than average payment rate increases with insurance plans in their 2023 contracts.

Hospice 276
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

As Headwinds Rage, Large Hospice Companies Lay Groundwork for Potential 2023 Growth

Hospice News

This year brought the return of Medicare sequestration, and pandemic-driven disruption in referral streams are lingering. This initiative is one example of investments and programs that companies are implementing this year that leaders expect to bear fruit in Q4 or next year. In September, we eliminated approximately $6.5

article thumbnail

Hospice News’ Top 10 Stories of 2022

Hospice News

In 2022, the hospice community laid the groundwork for a transformational 2023. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice regulations that will become effective on Jan. The insurance company will integrate LHC Group with its existing home health asset, Optum Health.

2022 246
article thumbnail

5 Most Game-Changing Hospice Deals from 2022

Hospice News

Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. billion to $1.08

2022 246